In this research proposal entitled, "Safety, efficacy and feasibility of intranasal ketamine for uncontrolled cancer pain, Dr. Singh aims to conduct a clinical trial among individuals with cancer-related pain to understand the effects of intranasal ketamine on patient reported outcomes and determine the opioid sparing effect of this novel use of ketamine. This is a second resubmission of the original proposal and shows significant improvement and progress from the prior submission.
As a candidate, Dr. Singh continues to show motivation and persistence in pursuing a research career and continues to make significant strides in moving the project along despite the lack of funding. She has obtained IRB and IND approval for the use on intranasal ketamine and has already started enrollment of subjects in the study. There was a concern in the previous application regarding the lack of publications, the mentorship and advisory team, but she has worked hard to address all of those concerns. With regards to protected time, it appears that she already has obtained approval for additional protected time to pursue MSCR training this fall. With this submission, it is becoming clearer that she does have departmental support, which was a previous concern. Importantly, she has made good progress even without significant resources.
The research plan itself is very feasible and enrollment has started even without funding at this point. Dr. Singh's training and background optimally positions her to access the many affected patients with cancer-related pain. Her primary mentor has a strong track record of mentorship and her mentorship and advisory team includes expertise in both pharmacology and statistics that will allow for successful completion of the proposed study. The career development plan is more developed in this resubmission, and her ideas for K23 funding are clearer. Still, specific details on how she plans to turn this study into future funding could be more developed, especially if this turns out that intranasal ketamine is not effective in improving patient reported outcomes or opioid sparing.
SCORED REVIEW CRITERIA
Reviewers will consider each of the five review criteria below in the determination of scientific and technical merit, and give a separate score for each. 
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As applicable for the project proposed, reviewers will consider the following additional items in the determination of scientific and technical merit, but will not give separate scores for these items. 
Resubmission
Comments: Second resubmission, and introduction addresses the concerns raised in the prior proposal
Budget

Recommended budget modifications
ADDITIONAL COMMENTS TO APPLICANT
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